Lung Ultrasound in Comparison With C.T in Covid-19
December 14, 2021 updated by: Esraa Mohamed Amin, Sohag University
Can Lung Ultrasound Play a Competitive Role With Computed Tomography in Diagnosis and Follow up of Covid-19 Patients?
investigate the diagnostic ability of thoracic ultrasound in suspicious COVID-19 infection and/or COVID-19 pneumonia.
Also, to compare its findings to CT and follow up these findings.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
ultrasound and C.T will be assessed in acute presentation of Covid 19 patients and then those patients will be reassessed again after 1 month by lung ultrasound and C.T and if ultrasound will show the same efficacy of diagnosis or not
Study Type
Observational
Enrollment (Anticipated)
200
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 95 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
covid 19 patients in acute phase and follow up after 1 and 2 months
Description
Inclusion Criteria:
- all cases of covid 19 patients
Exclusion Criteria:
- all other causes of consolidation ,ground glass fibrosis or collapse findings of C.T and ultrasound
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
covid 19 in acute phase
|
lung ultrasound in comparison to C.T
|
|
covid 19 follow up
|
lung ultrasound in comparison to C.T
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
diagnostic ability of thoracic ultrasound for diagnosis and follow up of covid19 patients
Time Frame: after 1 month of acute presentation
|
compare lung ultrasound with C.T finding of covid 19 patients
|
after 1 month of acute presentation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 1, 2022
Primary Completion (Anticipated)
January 1, 2024
Study Completion (Anticipated)
December 30, 2024
Study Registration Dates
First Submitted
December 12, 2021
First Submitted That Met QC Criteria
December 14, 2021
First Posted (Actual)
December 15, 2021
Study Record Updates
Last Update Posted (Actual)
December 15, 2021
Last Update Submitted That Met QC Criteria
December 14, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Soh-Med-21-12-16
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.